Geron Corp. (GERN)
1.585
+0.10
(+7.09%)
USD |
NASDAQ |
Sep 02, 16:00
1.57
-0.02
(-0.95%)
After-Hours: 16:13
Geron Cash from Investing (Quarterly) : 8.295M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.295M |
| March 31, 2026 | 51.86M |
| December 31, 2025 | 21.14M |
| September 30, 2025 | 13.35M |
| June 30, 2025 | 20.32M |
| March 31, 2025 | 52.44M |
| December 31, 2024 | -103.51M |
| September 30, 2024 | -0.554M |
| June 30, 2024 | -36.15M |
| March 31, 2024 | 34.21M |
| December 31, 2023 | 47.57M |
| September 30, 2023 | -4.714M |
| June 30, 2023 | -44.44M |
| March 31, 2023 | -178.73M |
| December 31, 2022 | 18.99M |
| September 30, 2022 | 9.842M |
| June 30, 2022 | 2.81M |
| March 31, 2022 | 30.43M |
| December 31, 2021 | 8.365M |
| September 30, 2021 | -5.406M |
| June 30, 2021 | 30.90M |
| March 31, 2021 | 38.08M |
| December 31, 2020 | -21.84M |
| September 30, 2020 | 13.56M |
| June 30, 2020 | -129.21M |
| Date | Value |
|---|---|
| March 31, 2020 | 32.16M |
| December 31, 2019 | -7.013M |
| September 30, 2019 | 6.037M |
| June 30, 2019 | 19.41M |
| March 31, 2019 | 8.964M |
| December 31, 2018 | 0.848M |
| September 30, 2018 | -9.349M |
| June 30, 2018 | -66.61M |
| March 31, 2018 | -2.608M |
| December 31, 2017 | 9.744M |
| September 30, 2017 | 7.722M |
| June 30, 2017 | -3.854M |
| March 31, 2017 | 9.358M |
| December 31, 2016 | 7.517M |
| September 30, 2016 | 4.148M |
| June 30, 2016 | 0.792M |
| March 31, 2016 | -3.694M |
| December 31, 2015 | 8.867M |
| September 30, 2015 | 5.72M |
| June 30, 2015 | 11.87M |
| March 31, 2015 | -26.39M |
| December 31, 2014 | 5.66M |
| September 30, 2014 | 2.447M |
| June 30, 2014 | 3.241M |
| March 31, 2014 | -89.78M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Precigen, Inc. | 26.69M |
| Editas Medicine, Inc. | -29.80M |
| Agenus, Inc. | 0.267M |
| Amgen, Inc. | -569.00M |
| Anika Therapeutics, Inc. | -1.28M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -15.83M |
| Cash from Financing (Quarterly) | 1.384M |
| Free Cash Flow | -114.76M |
| Free Cash Flow Per Share (Quarterly) | -0.0239 |
| Free Cash Flow to Equity (Quarterly) | -15.98M |
| Free Cash Flow to Firm (Quarterly) | -8.904M |
| Free Cash Flow Yield | -10.83% |